Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2
Condition(s):Sickle Cell DiseaseLast Updated:November 25, 2020Recruiting
Include Studies Not Open or Pending
Condition(s):Sickle Cell DiseaseLast Updated:November 25, 2020Recruiting
Condition(s):Thalassemia; Sickle Cell Disease; Healthy ControlsLast Updated:May 11, 2021Recruiting
Condition(s):Sickle-Cell Disease Nos With CrisisLast Updated:July 17, 2020Recruiting
Condition(s):Sickle Cell DiseaseLast Updated:April 1, 2022Recruiting
Condition(s):Sickle Cell DiseaseLast Updated:April 29, 2021Recruiting
Condition(s):Sickle Cell Anemia in Children; Sickle Cell DiseaseLast Updated:March 18, 2022Not yet recruiting
Condition(s):Cystic Fibrosis; Sickle Cell Disease; SARS CoV 2 InfectionLast Updated:May 4, 2022Recruiting
Condition(s):Sickle Cell Disease; Sickle Cell Anemia in Children; Sickle Cell Thalassemia; Sickle Cell SC DiseaseLast Updated:July 9, 2021Recruiting
Condition(s):Beta Thalassemia Intermedia; Sickle Cell DiseaseLast Updated:April 15, 2022Recruiting
Condition(s):Sickle Cell Disease; Cerebral StrokeLast Updated:November 9, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.